Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
No Relationships to Disclose |
|
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Corcept Therapeutics |
Recipient: Your Institution |
Company: Abbvie |
Recipient: Your Institution |
Company: Iovance Biotherapeutics |
Recipient: Your Institution |
Company: Sermonix Pharmaceuticals |
Recipient: Your Institution |
Company: Compugen |
Recipient: Your Institution |
Company: Roche |
Recipient: Your Institution |
Company: Celldex |
Recipient: Your Institution |
Company: AstraZeneca |
Recipient: Your Institution |
Company: Molecular Templates |
Recipient: Your Institution |
Company: Astellas Pharma |
Recipient: Your Institution |
Company: K Group beta |
Recipient: Your Institution |
Company: AstraZeneca |
Recipient: Your Institution |
Company: Compugen |
Recipient: Your Institution |
Company: Merck |
Recipient: Your Institution |
Company: Incyte |
Recipient: Your Institution |
Company: P{fizer |
Recipient: Your Institution |
Company: Artios |
Recipient: Your Institution |
Company: Blueprint Medicines |
Recipient: Your Institution |
Company: Duality Biologics |
Recipient: Your Institution |
Company: Sanofi |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
No Relationships to Disclose |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|